These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6765966)

  • 1. Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.
    Al-Rammahy AK; Levy JG; Jackson AL
    J Immunol; 1980 Jan; 124(1):143-50. PubMed ID: 6765966
    [No Abstract]   [Full Text] [Related]  

  • 2. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.
    Colmenero P; Liljeström P; Jondal M
    Gene Ther; 1999 Oct; 6(10):1728-33. PubMed ID: 10516722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of histocompatibility and tumour-associated antigens of the P-815 murine mastocytoma cell.
    Clemetson KJ; Gerber A; Bertschmann M; Lüscher EF
    Eur J Cancer (1965); 1976 Apr; 12(4):263-70. PubMed ID: 821757
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo production of chemotactic inhibitors by tumor cells.
    Cohen MC; Brozna JP; Ward PA
    Am J Pathol; 1979 Mar; 94(3):603-14. PubMed ID: 106732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells.
    La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB
    J Immunol; 1998 Dec; 161(12):6552-8. PubMed ID: 9862681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic uveitis. Studies on characterization and isolation of the pathogenic retina antigen.
    Wacker WB
    Int Arch Allergy Appl Immunol; 1973; 45(5):639-56. PubMed ID: 4201409
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymerised autologous tumor tissue particles in experimental cancer immunotherapy with special reference to the effects on the immune system of the host.
    Syrjänen KJ; Soimakallio S
    Arch Geschwulstforsch; 1980; 50(8):724-34. PubMed ID: 6784699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 11. Some properties of polyoma virus "T" and "tumour" antigens.
    Zembala M; Ptak W; Porwit-Bobr Z
    Z Immunitatsforsch Exp Klin Immunol; 1970; 141(1):27-36. PubMed ID: 4323568
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and properties of antisera directed against antigens of the P-815 mastocytoma cell not shared by its syngeneic host, the DBA/2 mouse.
    Bertschmann M; Clemetson KJ; Lüscher EF
    Eur J Cancer (1965); 1976 Apr; 12(4):255-62. PubMed ID: 60238
    [No Abstract]   [Full Text] [Related]  

  • 13. LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors.
    Abina MA; Lee MG; Descamps V; Cordier L; Lopez M; Perricaudet M; Haddada H
    Gene Ther; 1996 Mar; 3(3):212-6. PubMed ID: 8646551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.
    Tamerius J; Nepom J; Hellström I; Hellström KE
    J Immunol; 1976 Mar; 116(3):724-30. PubMed ID: 1254951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.
    Goldberg EH; Tokuda S
    Transplant Proc; 1977 Jun; 9(2):1363-5. PubMed ID: 878010
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody mediated neutralization of immunosuppression induced by mastocytoma ascites fluids.
    Watanabe M; Pan S; Friedman H
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):238-41. PubMed ID: 79184
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 20. Human T cell leukemia antigens on the cell membranes: purification molecular characterization, and preparation of specific antisera.
    Seon BK; Negoro S; Minowada J; Yoshizaki K
    J Immunol; 1981 Dec; 127(6):2580-8. PubMed ID: 6975329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.